title: Results from an international case-control study of childhood brain tumors: the role of prenatal vitamin supplementation.
abstract: An international case-control study of primary pediatric brain tumors included interviews with mothers of cases diagnosed from 1976 to 1994 and mothers of population controls. Data are available on maternal vitamin use during pregnancy for 1051 cases and 1919 controls from eight geographic areas in North America, Europe, and Israel. Although risk estimates varied by study center, combined results suggest that maternal supplementation for two trimesters may decrease risk of brain tumor (odds ratio [OR] 0.7, 95% confidence interval [CI] 0.5-0.9), with a trend of less risk with longer duration of use (p trend = 0.0007). The greatest risk reduction was among children diagnosed under 5 years of age whose mothers used supplements during all three trimesters (OR 0.5, CI 0.3-0.8). This effect did not vary by histology and was seen for supplementation during pregnancy rather than during the month before pregnancy or while breast feeding. These findings are largely driven by data from the United States, where most mothers took vitamins. The proportion of control mothers who took vitamins during pregnancy varied tremendously: from 3% in Israel and France, 21% in Italy, 33% in Canada, 52% in Spain and 86 to 92% at the three U.S. centers. The composition of the various multivitamin compounds taken also varied: the daily dose of vitamin C ranged from 0 to 600 mg, vitamin E ranged from 0 to 70 mg, vitamin A ranged from 0 to 30,000 IU, and folate ranged from 0 to 2000 micrograms. Mothers also took individual micronutrient supplements (e.g., vitamin C tablets), but most mothers who took these also took multivitamins, making it impossible to determine potential independent effects of these micronutrients.
authors.affiliation: Department of Preventive Medicine, University of Southern California, Los Angeles, USA. spresto@hsc.usc.edu
authors.forename: S
authors.initials: S
authors.lastname: Preston-Martin
authors.forename: J M
authors.initials: JM
authors.lastname: Pogoda
authors.forename: B A
authors.initials: BA
authors.lastname: Mueller
authors.forename: F
authors.initials: F
authors.lastname: Lubin
authors.forename: B
authors.initials: B
authors.lastname: Modan
authors.forename: E A
authors.initials: EA
authors.lastname: Holly
authors.forename: G
authors.initials: G
authors.lastname: Filippini
authors.forename: S
authors.initials: S
authors.lastname: Cordier
authors.forename: R
authors.initials: R
authors.lastname: Peris-Bonet
authors.forename: W
authors.initials: W
authors.lastname: Choi
authors.forename: J
authors.initials: J
authors.lastname: Little
authors.forename: A
authors.initials: A
authors.lastname: Arslan
mesh_terms: D000293:Adolescent; D001932:Brain Neoplasms / Q000453:epidemiology* / Q000517:prevention & control; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D016001:Confidence Intervals; D019587:Dietary Supplements / Q000706:statistics & numerical data*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007391:International Cooperation; D016013:Likelihood Functions; D008297:Male; D016017:Odds Ratio; D011247:Pregnancy; D011295:Prenatal Care / Q000706:statistics & numerical data*; D020011:Protective Agents / Q000008:administration & dosage; D014815:Vitamins / Q000008:administration & dosage
chemical_list: D020011:Protective Agents; D014815:Vitamins